Simon Quick Advisors LLC Purchases 778 Shares of Stryker Corporation $SYK

Simon Quick Advisors LLC lifted its stake in Stryker Corporation (NYSE:SYK) by 25.6% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,816 shares of the medical technology company’s stock after purchasing an additional 778 shares during the quarter. Simon Quick Advisors LLC’s holdings in Stryker were worth $1,510,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in SYK. Mid American Wealth Advisory Group Inc. bought a new stake in shares of Stryker in the 2nd quarter worth approximately $26,000. Sachetta LLC raised its position in shares of Stryker by 58.7% in the 2nd quarter. Sachetta LLC now owns 73 shares of the medical technology company’s stock worth $29,000 after purchasing an additional 27 shares during the last quarter. Ridgewood Investments LLC raised its position in shares of Stryker by 48.4% in the 2nd quarter. Ridgewood Investments LLC now owns 92 shares of the medical technology company’s stock worth $36,000 after purchasing an additional 30 shares during the last quarter. Ransom Advisory Ltd purchased a new position in shares of Stryker in the 1st quarter worth about $37,000. Finally, Solstein Capital LLC purchased a new position in shares of Stryker in the 2nd quarter worth about $43,000. 77.09% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on SYK. Barclays lifted their price target on Stryker from $443.00 to $453.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 22nd. Truist Financial lowered their price objective on Stryker from $415.00 to $407.00 and set a “hold” rating on the stock in a research report on Wednesday, October 15th. Rothschild & Co Redburn initiated coverage on Stryker in a research report on Thursday, September 18th. They issued a “neutral” rating and a $420.00 price objective on the stock. Redburn Partners set a $420.00 price objective on Stryker in a research report on Thursday, September 18th. Finally, Rothschild Redb raised Stryker to a “hold” rating in a research report on Thursday, September 18th. Thirteen research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, Stryker has a consensus rating of “Moderate Buy” and a consensus target price of $434.32.

Insider Transactions at Stryker

In other Stryker news, insider Viju Menon sold 500 shares of the business’s stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $390.61, for a total transaction of $195,305.00. Following the completion of the sale, the insider directly owned 12,511 shares in the company, valued at $4,886,921.71. The trade was a 3.84% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Ronda E. Stryker sold 200,000 shares of the business’s stock in a transaction dated Wednesday, August 6th. The shares were sold at an average price of $376.45, for a total value of $75,290,000.00. Following the sale, the director owned 3,222,108 shares of the company’s stock, valued at approximately $1,212,962,556.60. This represents a 5.84% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 5.90% of the company’s stock.

Stryker Stock Performance

SYK stock opened at $369.31 on Friday. The stock’s 50 day simple moving average is $378.83 and its 200 day simple moving average is $380.54. The stock has a market capitalization of $141.19 billion, a PE ratio of 48.92, a price-to-earnings-growth ratio of 2.66 and a beta of 0.94. The company has a current ratio of 1.78, a quick ratio of 1.06 and a debt-to-equity ratio of 0.70. Stryker Corporation has a 12-month low of $329.16 and a 12-month high of $406.19.

Stryker (NYSE:SYK) last released its quarterly earnings results on Thursday, October 30th. The medical technology company reported $3.19 earnings per share for the quarter, beating the consensus estimate of $3.13 by $0.06. The firm had revenue of $6.06 billion for the quarter, compared to analysts’ expectations of $6.04 billion. Stryker had a return on equity of 23.94% and a net margin of 12.25%.The company’s revenue was up 10.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.87 EPS. Stryker has set its FY 2025 guidance at 13.500-13.600 EPS. As a group, research analysts forecast that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be paid a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Tuesday, September 30th. Stryker’s payout ratio is currently 44.50%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.